Viridian Therapeutics Inc
F:1S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Viridian Therapeutics Inc
F:1S1
|
US |
|
T
|
Theratechnologies Inc
F:TQ8
|
CA |
|
R
|
Renta 4 Banco SA
F:4RE
|
ES |
|
Bank of America Corp
NYSE:BAC
|
US |
|
S
|
Sumitomo Corp
OTC:SSUMF
|
JP |
|
H
|
Henkel AG & Co KGaA
XHAM:HEN
|
DE |
|
Ajinomoto Co Inc
OTC:AJINF
|
JP |
|
S
|
Secure Energy Services Inc
F:SEP
|
CA |
|
B
|
Bayan Resources Tbk PT
XBER:BNB
|
ID |
|
C
|
Credito Emiliano SpA
SWB:EAO
|
IT |
|
L
|
Loblaw Companies Ltd
OTC:LBLCF
|
CA |
|
M
|
Melia Hotels International SA
XMUN:MEL
|
ES |
Bankruptcy Probability
Viridian Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Viridian Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Viridian Therapeutics Inc
NASDAQ:VRDN
|
1.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
372.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
164B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
OpGen Inc
NASDAQ:OPGN
|
156.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Viridian Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Viridian Therapeutics Inc has total debt of 86.5m USD. This includes both short-term (0 USD) and long-term (86.5m USD) debt.
You can find a full breakdown on its Balance Sheet.
